Bayer Cropscience Limited
Commodities›Chemicals›Fertilizers & Agrochemicals›Pesticides & Agrochemicals
Key metrics
Price as of 2026-07-20
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Standalone
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Only standalone filings are available for this company.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 983 Cr | 1,740 Cr | 1,617 Cr | 955 Cr | 792 Cr | 1,631 Cr | 1,738 Cr | 1,057 Cr | 1,046 Cr | 1,915 Cr | 1,553 Cr | 1,106 Cr |
| Operating expenses (approx.) | 774 Cr | 1,315 Cr | 1,312 Cr | 827 Cr | 695 Cr | 1,317 Cr | 1,554 Cr | 1,037 Cr | 876 Cr | 1,566 Cr | 1,348 Cr | 989 Cr |
| EBITDA | 209 Cr | 425 Cr | 305 Cr | 128 Cr | 97 Cr | 314 Cr | 184 Cr | 20 Cr | 171 Cr | 348 Cr | 205 Cr | 117 Cr |
| OPM % | 21.3% | 24.4% | 18.9% | 13.4% | 12.2% | 19.2% | 10.6% | 1.9% | 16.3% | 18.2% | 13.2% | 10.6% |
| Other income | 21 Cr | 21 Cr | 16 Cr | 15 Cr | 30 Cr | 28 Cr | 24 Cr | 33 Cr | 37 Cr | 19 Cr | 14 Cr | 16 Cr |
| Interest | 7 Cr | 8 Cr | 4 Cr | 3 Cr | 5 Cr | 4 Cr | 3 Cr | 4 Cr | 6 Cr | 5 Cr | 4 Cr | 5 Cr |
| Depreciation | 27 Cr | 31 Cr | 12 Cr | 15 Cr | 16 Cr | 22 Cr | 14 Cr | 15 Cr | 34 Cr | 27 Cr | 14 Cr | 15 Cr |
| Profit before tax | 195 Cr | 406 Cr | 306 Cr | 124 Cr | 105 Cr | 316 Cr | 190 Cr | 34 Cr | 168 Cr | 335 Cr | 200 Cr | 113 Cr |
| Tax % | 18.8% | 19.1% | 27.1% | 25.0% | 8.9% | 19.5% | 28.3% | -1.8% | 14.7% | 16.9% | 23.8% | 15.3% |
| Net profit | 159 Cr | 329 Cr | 223 Cr | 93 Cr | 96 Cr | 254 Cr | 136 Cr | 34 Cr | 143 Cr | 279 Cr | 153 Cr | 96 Cr |
| EPS (₹) | ₹35.27 | ₹73.09 | ₹49.60 | ₹20.72 | ₹21.36 | ₹56.56 | ₹30.33 | ₹7.61 | ₹31.88 | ₹62.01 | ₹33.98 | ₹21.29 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,686 Cr | 3,609 Cr | 4,261 Cr | 4,734 Cr | 5,140 Cr | 5,103 Cr | 5,473 Cr | Sign in for TTM |
| Operating expenses (approx.) | 2,313 Cr | 3,013 Cr | 3,445 Cr | 3,865 Cr | 4,112 Cr | 4,149 Cr | 4,784 Cr | Sign in for TTM |
| EBITDA | 373 Cr | 596 Cr | 817 Cr | 870 Cr | 1,028 Cr | 954 Cr | 690 Cr | Sign in for TTM |
| OPM % | 13.9% | 16.5% | 19.2% | 18.4% | 20.0% | 18.7% | 12.6% | Sign in for TTM |
| Other income | 37 Cr | 66 Cr | 64 Cr | 55 Cr | 64 Cr | 81 Cr | 120 Cr | Sign in for TTM |
| Interest | 10 Cr | 14 Cr | 13 Cr | 13 Cr | 22 Cr | 20 Cr | 17 Cr | Sign in for TTM |
| Depreciation | 34 Cr | 65 Cr | 74 Cr | 65 Cr | 80 Cr | 74 Cr | 85 Cr | Sign in for TTM |
| Profit before tax | 366 Cr | 583 Cr | 795 Cr | 847 Cr | 990 Cr | 941 Cr | 707 Cr | Sign in for TTM |
| Tax % | 35.1% | 18.6% | 37.9% | 23.8% | 23.4% | 21.3% | 19.7% | Sign in for TTM |
| Net profit | 238 Cr | 475 Cr | 493 Cr | 645 Cr | 758 Cr | 741 Cr | 568 Cr | Sign in for TTM |
| EPS (₹) | ₹69.20 | ₹105.58 | ₹109.72 | ₹143.58 | ₹168.71 | ₹164.77 | ₹126.38 | Sign in for TTM |
| Dividend payout % | — | — | — | 104.3% | 74.0% | 81.9% | 98.7% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Equity capital | 34 Cr | 45 Cr | 45 Cr | 45 Cr | 45 Cr | 45 Cr | 45 Cr |
| Reserves | 1,849 Cr | 2,528 Cr | 2,505 Cr | 2,479 Cr | 2,667 Cr | 2,805 Cr | 2,806 Cr |
| Borrowings | — | 2 Cr | — | — | — | — | — |
| Other liabilities | 1,018 Cr | 1,262 Cr | 1,689 Cr | 1,829 Cr | 1,967 Cr | 1,748 Cr | 2,396 Cr |
| Total liabilities | 2,902 Cr | 3,836 Cr | 4,239 Cr | 4,353 Cr | 4,679 Cr | 4,597 Cr | 5,246 Cr |
| Fixed assets (net) | 293 Cr | 436 Cr | 393 Cr | 437 Cr | 428 Cr | 376 Cr | 427 Cr |
| CWIP | 0.70 Cr | 4 Cr | 8 Cr | 13 Cr | 3 Cr | 6 Cr | 0.50 Cr |
| Investments | 351 Cr | 41 Cr | 52 Cr | 39 Cr | 41 Cr | 54 Cr | 35 Cr |
| Other assets | 2,091 Cr | 3,014 Cr | 3,544 Cr | 3,576 Cr | 3,896 Cr | 3,906 Cr | 4,472 Cr |
| Total assets | 2,902 Cr | 3,836 Cr | 4,239 Cr | 4,353 Cr | 4,679 Cr | 4,597 Cr | 5,246 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 216 Cr | 609 Cr | 952 Cr | 262 Cr |
| Cash from investing | — | — | — | 64 Cr | 83 Cr | 0.40 Cr | 86 Cr |
| Cash from financing | — | — | — | -703 Cr | -613 Cr | -656 Cr | -619 Cr |
| Net cash flow | — | — | — | -424 Cr | 80 Cr | 296 Cr | -271 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 182 Cr | 565 Cr | 919 Cr | 236 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| ROCE % | 18.0% | 20.6% | 29.1% | 31.9% | 35.0% | 30.9% | 21.2% |
| ROE % | 12.6% | 18.4% | 19.3% | 25.6% | 28.0% | 26.0% | 19.9% |
| Debtor days | 80 | 73 | 64 | 77 | 69 | 69 | 63 |
| Inventory days | 231 | 201 | 194 | 213 | 259 | 207 | 240 |
| Days payable | 131 | 99 | 122 | 116 | 125 | 81 | 111 |
| Cash conversion cycle | 180 | 174 | 137 | 175 | 203 | 195 | 192 |
| Debt / equity | — | 0.0006 | 0.00 | — | — | — | — |
| Current ratio | 2.31 | 2.65 | 2.26 | 2.15 | 2.19 | 2.44 | 2.01 |
| Net debt / EBITDA | -0.88 | -1.79 | -1.47 | -0.90 | -0.84 | -1.21 | -1.28 |
Compare with peers
Loading peers…